RESEARCH STRATEGY A. Significance Advances in the understanding of the HIV-1 virus have led to the development of a large armamentarium of antiretroviral agents and the availability of a variety of efficacious strategies to prevent HIV transmission. However, large gaps exist between the potential for individual and population-level benefit inherent in these efficacious strategies, and the effectiveness observed clinically and at the population level. WHO estimates that expanded use of existing prevention tools could avert half of the 62 million new HIV infections projected to occur by 2015.[29] Similar gaps have been found with respect to the treatment of HCV among drug users, where clinical trials have demonstrated the superior efficacy of combination therapy for HCV with interferon, ribavirin and new direct acting antivirals, yet many HCV infected persons, particularly SUs, do not become engaged in HCV treatment Further, the impact of efficacious strategies is unevenly distributed, and significant health care disparities exist, particularly impacting racial and ethnic minorities and those without health insurance. As treatment has improved and HIV infected persons live longer, multiple comorbidities contribute to morbidity and mortality.[30] In areas where ART is widely available, liver disease, including HIV-HCV confection, has emerged as a significant cause of morbidity and mortality.[31-34] In some areas where ART has been implemented, drug resistant HIV has become more prevalent due to the complex interplay of individual barriers and access to care.[35,36] The Infectious Disease Core was established in CDUHR-III based on the recognition of the growing importance of biomedical issues affecting the HIV epidemic among drug users, including: the increasing role of sexual HIV transmission among SUs and high risk heterosexuals,[12,13,37] the hyperendemicity of hepatitis C virus (HCV) infection and HIV/HCV co-infection in drug users, issues with access to HCV. care, and HIV/TB confection. [38-42] During the course of CDUHR-III, biomedical advances, particularly antiretroviral therapy (ART), have further improved longevity and quality of life for PLWHA, but have not achieved their full potential because of barriers to full implementation.[43-45] Further, there was the recognition that the complexity and multilevel issues posed by the HIV epidemic among SUs and others would require both multidisciplinary study and multilevel intervention. The ID Core was created to enhance and support the biomedical knowledge base among CDUHR investigators in relevant scientific areas related to ID pathogenesis, natural history, and clinical care, and to foster the multidisciplinary study of HIV and other relevant issues among SUs. As newer biomedical interventions have been introduced (including PrEP, PEP, circumcision), there has been an increasing need for incorporating socio-behavioral expertise in successfully implementing these approaches. Further, the Affordable Health Care Act of 2010 may have a significant impact on the implementation phase of research translation. Thus, it is essential that CDUHR investigators are knowledgeable about biomedical trends and advances related to HIV and substance use and about changes in health care delivery. We will discuss several specific Issues relevant to HIV and infectious diseases affecting SUs that the IDB Core will address in the renewal. These issues are relevant to existing and planned projects within CDUHR and to the work of the IDB Core members. The specific topics are: A.1. Developments in HIV and substance use prevention and treatment;clinical implementation issues A.2. Health Care disparities A.S. HCV care for SUs, including for HIV-HCV co-infection A.4. Aging and comorbidities among PLWHA A.5. Health services for HIV and related conditions in SUs, and impact of changes in health care policy A.6. Genomic and Personalized Medicine for HIV, HCV, and related conditions of SUs A.7. The importance of Interprofessional Education (IPE)

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA011041-16
Application #
8408715
Study Section
Special Emphasis Panel (ZDA1-EXL-T (03))
Project Start
Project End
Budget Start
2013-04-15
Budget End
2013-12-31
Support Year
16
Fiscal Year
2013
Total Cost
$116,947
Indirect Cost
$16,598
Name
New York University
Department
Type
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Palamar, Joseph J; Acosta, Patricia; Sherman, Scott et al. (2016) Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. Am J Drug Alcohol Abuse 42:624-632
Jarlais, Don C Des; Arasteh, Kamyar; Feelemyer, Jonathan et al. (2016) From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits. J Subst Abuse Treat 71:48-53
Morgan, Ethan; Khanna, Aditya S; Skaathun, Britt et al. (2016) Marijuana Use Among Young Black Men Who Have Sex With Men and the HIV Care Continuum: Findings From the uConnect Cohort. Subst Use Misuse 51:1751-9
Gelpí-Acosta, Camila; Pouget, Enrique R; Reilly, Kathleen H et al. (2016) Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City. Subst Use Misuse 51:870-81
Kurth, Ann E; Cleland, Charles M; Chhun, Nok et al. (2016) Accuracy and Acceptability of Oral Fluid HIV Self-Testing in a General Adult Population in Kenya. AIDS Behav 20:870-9
Friedman, Samuel R; Pouget, Enrique R; Sandoval, Milagros et al. (2016) Interpersonal Attacks on the Dignity of Members of HIV Key Populations: A Descriptive and Exploratory Study. AIDS Behav :
Gwadz, Marya; Cleland, Charles M; Kutnick, Alexandra et al. (2016) Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection in New York City. Front Public Health 4:76
Reed, Jennifer R; Jordan, Ashly E; Perlman, David C et al. (2016) The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis. Syst Rev 5:110
Gwadz, Marya; Cleland, Charles M; Jenness, Samuel M et al. (2016) Exploring Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection Recruited with Venue-based Sampling. J AIDS Clin Res 7:
Vasylyeva, Tetyana I; Friedman, Samuel R; Paraskevis, Dimitrios et al. (2016) Integrating molecular epidemiology and social network analysis to study infectious diseases: Towards a socio-molecular era for public health. Infect Genet Evol 46:248-255

Showing the most recent 10 out of 217 publications